Bache, M.; Heise, N.V.; Thiel, A.; Funtan, A.; Seifert, F.; Petrenko, M.; Güttler, A.; Brandt, S.; Mueller, T.; Vordermark, D.;
et al. Combination of Betulinic Acid Fragments and Carbonic Anhydrase Inhibitors—A New Drug Targeting Approach. Pharmaceutics 2024, 16, 401.
https://doi.org/10.3390/pharmaceutics16030401
AMA Style
Bache M, Heise NV, Thiel A, Funtan A, Seifert F, Petrenko M, Güttler A, Brandt S, Mueller T, Vordermark D,
et al. Combination of Betulinic Acid Fragments and Carbonic Anhydrase Inhibitors—A New Drug Targeting Approach. Pharmaceutics. 2024; 16(3):401.
https://doi.org/10.3390/pharmaceutics16030401
Chicago/Turabian Style
Bache, Matthias, Niels V. Heise, Andreas Thiel, Anne Funtan, Franziska Seifert, Marina Petrenko, Antje Güttler, Sarah Brandt, Thomas Mueller, Dirk Vordermark,
and et al. 2024. "Combination of Betulinic Acid Fragments and Carbonic Anhydrase Inhibitors—A New Drug Targeting Approach" Pharmaceutics 16, no. 3: 401.
https://doi.org/10.3390/pharmaceutics16030401
APA Style
Bache, M., Heise, N. V., Thiel, A., Funtan, A., Seifert, F., Petrenko, M., Güttler, A., Brandt, S., Mueller, T., Vordermark, D., Thondorf, I., Csuk, R., & Paschke, R.
(2024). Combination of Betulinic Acid Fragments and Carbonic Anhydrase Inhibitors—A New Drug Targeting Approach. Pharmaceutics, 16(3), 401.
https://doi.org/10.3390/pharmaceutics16030401
